Tessa Romero
Stock Analyst at J.P. Morgan
(4.42)
# 1,155
Out of 5,108 analysts
215
Total ratings
45.2%
Success rate
13.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tessa Romero
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPTX Seaport Therapeutics | Reiterated: Buy | $42 → $41 | $20.39 | +101.08% | 3 | Nov 5, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Hold | n/a | $28.27 | - | 18 | Oct 31, 2026 | |
| ADRX ADARx Pharmaceuticals | Initiated Coverage: Buy | $38 | $13.29 | +185.93% | 1 | Oct 20, 2026 | |
| EYPT EyePoint | Downgraded: Sell | n/a | $0.3559 | - | 9 | Oct 19, 2026 | |
| PRAX Praxis Precision Medicines | Initiated Coverage: Buy | $700 | $262.59 | +166.58% | 1 | Oct 15, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $55.55 | - | 35 | Oct 14, 2026 | |
| DFTX Definium Therapeutics | Initiated Coverage: Buy | $84 | $30.36 | +176.68% | 1 | Oct 9, 2026 | |
| WVE Wave Life Sciences | Downgraded: Hold | n/a | $3.22 | - | 1 | Sep 23, 2026 | |
| SRRK Scholar Rock Holding | Rated: Buy | $70 | $45.50 | +53.85% | 12 | Sep 21, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $82 | $37.68 | +117.62% | 17 | Sep 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.90 | - | 15 | Sep 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $10 | $17.36 | -42.40% | 15 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $60 | $38.87 | +54.36% | 22 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $48 | $47.35 | +1.37% | 4 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $20 | $6.83 | +192.83% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $3.21 | +180.37% | 11 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.32 | +287.93% | 2 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.91 | +209.81% | 4 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.84 | - | 3 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.487 | - | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.44 | - | 2 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $34 | $21.24 | +60.08% | 19 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.45 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.09 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.34 | n/a | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $10 | $7.96 | n/a | 2 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.71 | n/a | 1 | Nov 9, 2020 |
Seaport Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $42 → $41
Current: $20.39
Upside: +101.08%
Agios Pharmaceuticals
Oct 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $28.27
Upside: -
ADARx Pharmaceuticals
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $13.29
Upside: +185.93%
EyePoint
Oct 19, 2026
Downgraded: Sell
Price Target: n/a
Current: $0.3559
Upside: -
Praxis Precision Medicines
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $700
Current: $262.59
Upside: +166.58%
Cytokinetics
Oct 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.55
Upside: -
Definium Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $84
Current: $30.36
Upside: +176.68%
Wave Life Sciences
Sep 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.22
Upside: -
Scholar Rock Holding
Sep 21, 2026
Rated: Buy
Price Target: $70
Current: $45.50
Upside: +53.85%
Xenon Pharmaceuticals
Sep 19, 2026
Reiterated: Buy
Price Target: $82
Current: $37.68
Upside: +117.62%
Sep 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.90
Upside: -
Sep 8, 2026
Downgraded: Sell
Price Target: $10
Current: $17.36
Upside: -42.40%
Aug 20, 2026
Rated: Buy
Price Target: $53 → $60
Current: $38.87
Upside: +54.36%
Aug 19, 2026
Reiterated: Buy
Price Target: $38 → $48
Current: $47.35
Upside: +1.37%
Aug 14, 2026
Rated: Buy
Price Target: $23 → $20
Current: $6.83
Upside: +192.83%
Aug 14, 2026
Reiterated: Hold
Price Target: $8 → $9
Current: $3.21
Upside: +180.37%
Jun 29, 2026
Reiterated: Buy
Price Target: $9
Current: $2.32
Upside: +287.93%
Jun 25, 2026
Reiterated: Buy
Price Target: $9
Current: $2.91
Upside: +209.81%
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.84
Upside: -
May 26, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.487
Upside: -
Apr 2, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.44
Upside: -
Mar 4, 2026
Rated: Buy
Price Target: $31 → $34
Current: $21.24
Upside: +60.08%
Nov 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.45
Upside: -
Oct 23, 2024
Downgraded: Sell
Price Target: n/a
Current: $2.09
Upside: n/a
Oct 18, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Jul 13, 2022
Downgraded: Hold
Price Target: $22 → $10
Current: $7.96
Upside: n/a
Nov 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $45.71
Upside: n/a